Piia Lavikainen

Koponen, Marjaana; Rajamaki, Blair; Lavikainen, Piia; Bell, J. Simon; Taipale, Heidi; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease Journal of the american medical directors association [in press]: 1-7. 2022

Alajärvi, Lasse; Timonen, Johanna; Lavikainen, Piia; Martikainen, Janne. 2021. Attitudes and Considerations towards Pharmaceuticals-Related Environmental Issues among Finnish Population Sustainability 13 22: 12930. 2021

Inglin, Laura; Lavikainen, Piia; Jalkanen, Kari; Laatikainen, Tiina. 2021. LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model Scientific reports 11 1: 22603. 2021

Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. 2021. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis Bmc health services research 21 1: 916. 2021

Lappalainen, Laura; Stenvall, Harriet; Lavikainen, Piia; Miettinen, Heikki; Martikainen, Janne; Sintonen, Harri; Tolppanen, Anna-Maija; Roine, Risto P; Hartikainen, Juha. 2021. Patient-reported outcomes in coronary artery disease: the relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D Health and quality of life outcomes 19 1: 206. 2021

Martikainen, Janne; Jalkanen, Kari; Heiskanen, Jari; Lavikainen, Piia; Peltonen, Markku; Laatikainen, Tiina; Lindström, Jaana. 2021. Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland Nutrients 13 10: 3583. 2021

Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. 2021. Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla Lääkärilehti 76 1-2: 48-52. 2021

Pisa, Federica; Reinold, Jonas; Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2021. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease Clinical epidemiology 13: 295-307. 2021

Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2020. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes Bmc health services research 20: 1095. 2020

Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. 2020. Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes Health policy 124 12: 1310-1316. 2020

Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Length of hospital stay for hip fracture and 30-day mortality in people with Alzheimer's disease: a cohort study in Finland Journals of gerontology series a: biological sciences and medical sciences 75 11: 2184-2192. 2020

Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease Neurology 94 20: e2099-e2108. 2020

Tapiainen, V; Lavikainen, P; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2020. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease Journal of the american geriatrics society 68 3: 595-602. 2020

Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease Journal of the american medical directors association 20 6: 751-758. 2019

Kalamägi, J; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2019. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease Annals of medicine 51 5-6: 294-305. 2019

Koponen, Marjaana; Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease Journal of the american medical directors association 20 12: 1488-1494.e3. 2019

Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J. 2019. Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population Health and quality of life outcomes 17: 117. 2019

Hamina, Aleksi; Lavikainen, Piia; Tanskanen, Antti; Tolppanen, Anna-Maija; Tiihonen, Jari; Hartikainen, Sirpa; Taipale, Heidi. 2018. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease INTERNATIONAL PSYCHOGERIATRICS 30 7: 947-956. 2018

Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen; Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study Journal of the American Heart Association 7 18: e009742. 2018

Sarycheva, Tatyana; Taipale, Heidi; Lavikainen, Piia; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease Journal of Alzheimer's Disease 66 1: 387-395. 2018

Tolppanen, Anna-Maija; Tiihonen, Miia; Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Lavikainen, Piia; Tiihonen, Jari; Hartikainen, Sirpa. 2018. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study DRUGS & AGING 35 11: 985-992. 2018

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. 2017. Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer's disease. JOURNAL OF CLINICAL PSYCHIATRY 78 3: e257-e263. 2017

Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Tolppanen Anna-Maija. 2017. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study Alzheimer's research and therapy 9 1: 59. 2017

Taipale Heidi, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa. 2017. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling persons with Alzheimer's disease. CANADIAN MEDICAL ASSOCIATION JOURNAL 189 14: E519-E529. 2017

Tolppanen A-M, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. 2017. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLOS ONE 12 3: e0173450. 2017

Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. 2017. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26 8: 875-889. 2017

Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2016. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 6 7: e012100. 2016

Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Psykoosilääkkeet yhteydessä Alzheimer-potilaiden keuhkokuumeriskiin. DUODECIM 132 16: 1490. 2016

Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and without Alzheimer's disease. CHEST 150 6: 1233-1241. 2016

Tolppanen Anna-Maija, Ahonen Riitta, Koponen Marjaana, Lavikainen Piia, Purhonen Maija, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Tiihonen Miia, Hartikainen Sirpa. 2016. Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. Journal of Preventive Medicine and Public Health 49 2: 134-138. 2016

Koponen Marjaana, Taipale Heidi, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Tolppanen Anna-Maija, Ahonen Riitta, Hartikainen Sirpa. 2016. Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease. Journal of Alzheimer's Disease 2017; 56 1: 107-118. 2016

Lampela Pasi, Taipale Heidi, Lavikainen Piia, Hartikainen Sirpa. 2016. The effect of comprehensive geriatric assessment on anticholinergic exposure assessed by four ranked anticholinergic lists. ARCHIVES OF GERONTOLOGY AND GERIATRICS (LIMERICK) 68 (2017): 195-201. 2016

Lavikainen Piia, Leskinen Esko, Hartikainen Sirpa, Möttönen Jyrki, Sulkava Raimo, Korhonen Maarit J.. 2015. Impact of missing data mechanism on the estimate of change: a case study on cognitive function and polypharmacy among older persons. Clinical Epidemiology 7: 169-180. 2015

Laitinen Marja-Liisa, Lönnroos Eija, Bell J. Simon, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2014. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study. INTERNATIONAL PSYCHOGERIATRICS 2015; 27 4: 669-672. 2014

Lampela Pasi, Lavikainen Piia, Garcia-Horsman J. Arturo, Bell J. Simon, Huupponen Risto, Hartikainen Sirpa. 2013. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. DRUGS & AGING 30 5: 321-330. 2013

Lampela Pasi, Lavikainen Piia, Huupponen Risto, Leskinen Esko, Hartikainen Sirpa. 2013. Comprehensive geriatric assessment decreases prevalence of orthostatic hypotension in older persons. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 41: 351-358. 2013

Puolakka Elina, Aaltonen Katri, Lavikainen Piia, Hartikainen Sirpa. 2013. Ei-korvattavien lääkkeiden käyttö kuopiolaisilla iäkkäillä vuonna 2007. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 29 3: 153-163. 2013

Tolppanen A-M, Lavikainen P, Soininen H, Hartikainen S. 2013. Incident Hip Fractures among Community Dwelling Persons with Alzheimer's Disease in a Finnish Nationwide Register-Based Cohort. PLOS ONE [ONLINE] 8 3: e59124. 2013

Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Soininen Hilkka, Hartikainen Sirpa. 2013. Incidence of stroke in people with Alzheimer disease. A national register-based approach. NEUROLOGY 80 4: 353-358. 2013

Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Uusitupa Matti, Soininen Hilkka, Hartikainen Sirpa. 2013. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. DIABETES CARE 36: 2015-2019. 2013

Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2013. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clinical Epidemiology 5: 277-285. 2013

Lihavainen Katri, Sipilä Sarianna, Rantanen Taina, Seppänen Jarmo, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2012. Effects of comprehensive geriatric intervention on physical performance among people aged 75 years and over. Aging Clinical and Experimental Research 24: 331-338. 2012

Saastamoinen Leena K, Wallin Mika, Lavikainen Piia, Airaksinen Marja S, Sourander Andre, Bell J. Simon. 2012. Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 68 7: 1109-1117. 2012

Desplenter Franciska, Lavikainen Piia, Hartikainen Sirpa, Sulkava Raimo, Bell J. Simon. 2012. Sedative use and incident cognitive decline among persons aged 75 years and older: a population-based longitudinal study. INTERNATIONAL PSYCHOGERIATRICS 24 1: 48-54. 2012

Bell J Simon, Ahonen Jouni, Lavikainen Piia, Hartikainen Sirpa. 2012. Potentially inappropriate drug use among older persons in Finland: application of a new national categorization. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2013:69: 657-664. 2012

Bell J Simon, Laitinen Marja-Liisa, Lavikainen Piia, Lönnroos Eija, Uosukainen Hanna, Hartikainen Sirpa. 2011. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland PAIN 152: 543 - 547. 2011

Bell J Simon, Lavikainen Piia, Korhonen Mikko, Hartikainen Sirpa. 2011. Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 67: 105 - 106. 2011

Bell J Simon, Lönnroos Eija, Koivisto Anne M, Lavikainen Piia, Laitinen Marja-Liisa, Soininen Hilkka, Hartikainen Sirpa. 2011. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland. Journal of Alzheimer's Disease 26: 231-237. 2011

Jyrkkä Johanna, Enlund Hannes, Lavikainen Piia, Sulkava Raimo, Hartikainen Sirpa. 2011. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 20: 514 - 522. 2011

Laitinen Marja-Liisa, Bell Simon, Lavikainen Piia, Lönnroos Eija, Sulkava Raimo, Hartikainen Sirpa. 2011. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland INTERNATIONAL PSYCHOGERIATRICS 23 10: 1623-1631. 2011

Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SY, Kettunen R, Huupponen R.. 2011. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 71 5: 766-776. 2011

Aaltonen K, Lavikainen P, Bell JS & Hartikainen S. 2010. Mitä ei-korvattuja lääkkeitä yli 75-vuotiaat kuopiolaiset käyttävät?, Farmasian Päivät 19. - 21.11.2010 Ratkaisuja tulevaisuuteen - Bringar nytt i dagen. 92-93. 2010

Helin-Salmivaara Arja, Lavikainen Piia T, Korhonen Maarit J, Halava Heli, Martikainen Jaana E, Saastamoinen Leena K, Virta Lauri, Klaukka Timo, Huupponen Risto. 2010. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study The American Journal of Managed Care 16 2: 116-122. 2010

Ilomäki J, Korhonen MJ, Lavikainen P, Lipton R, Enlund H & Kauhanen J. 2010. Changes in alcohol consumption and drinking patterns during 11 years of follow-up among ageing men: the FinDrink study. EUROPEAN JOURNAL OF PUBLIC HEALTH 20 2: 133 - 138. 2010

Lampela P, Hartikainen S, Lavikainen P, Sulkava R & Huupponen R. 2010. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. DRUGS & AGING 27 6: 507-521. 2010

Saastamoinen LK, Wallin M, Lavikainen P, Airaksinen MS & Bell JS. 2010. Persistence with selective serotonin reuptake inhibitor treatment among children and adolescents in Finland: a nationwide register study. Oral communicatios, 16th International Social Pharmacy Workshop 23.-26.8.2010 Lisboa, Portugal. Pharmacy Practice (Internet) Vol. 8 (suppl 1). 62-63. 2010

Tuikkala P, Hartikainen S, Korhonen MJ, Lavikainen P, Kettunen R, Sulkava R & Enlund H. 2010. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 28: 121-127. 2010

Hartikainen S, Lavikainen P, Raunio H, Ahonen J, Peura P, Martikainen J, Klaukka T. 2009. Mahahaavalääkitys pienemmin kustannuksin. SUOMEN LÄÄKÄRILEHTI 64 4: 296-299. 2009

Helin-Salmivaara A, Lavikainen P, Ruokoniemi P, Korhonen Maarit, Huupponen R. 2009. Persistence with statin therapy in diabetic and non-diabetic persons. a nation-wide register study in 1995-2005 in Finland. DIABETES RESEARCH AND CLINICAL PRACTICE 84: e9-e11. 2009

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

Avainsanat

Tutkimusryhmät - UEF

Linkit

Julkaisut